Rationale, Design, and Baseline Characteristics of the CURRENT AS Registry-2.


Journal

Circulation journal : official journal of the Japanese Circulation Society
ISSN: 1347-4820
Titre abrégé: Circ J
Pays: Japan
ID NLM: 101137683

Informations de publication

Date de publication:
25 10 2022
Historique:
pubmed: 22 4 2022
medline: 29 10 2022
entrez: 21 4 2022
Statut: ppublish

Résumé

There is scarce data evaluating the current practice pattern and clinical outcomes for patients with severe aortic stenosis (AS), including both those who underwent surgical aortic valve replacement (SAVR) or transcatheter aortic valve implantation (TAVI) and those who were managed conservatively in the TAVI era.Methods and Results: The Contemporary outcomes after sURgery and medical tREatmeNT in patients with severe Aortic Stenosis (CURRENT AS) Registry-2 is a prospective, physician-initiated, multicenter registry enrolling consecutive patients who were diagnosed with severe AS between April 2018 and December 2020 among 21 centers in Japan. The rationale for the prospective enrollment was to standardize the assessment of symptomatic status, echocardiographic evaluation, and other recommended diagnostic examinations such as computed tomography and measurement of B-type natriuretic peptide. Moreover, the schedule of clinical and echocardiographic follow up was prospectively defined and strongly recommended for patients who were managed conservatively. The entire study population consisted of 3,394 patients (mean age: 81.6 years and women: 60%). Etiology of AS was degenerative in 90% of patients. AS-related symptoms were present in 60% of patients; these were most often heart failure symptoms. The prevalence of high- and low-gradient AS was 58% and 42%, respectively, with classical and paradoxical low-flow low-gradient AS in 4.6% and 6.7%, respectively. The CURRENT AS Registry-2 might be large and meticulous enough to determine the appropriate timing of intervention for patients with severe AS in contemporary clinical practice.

Sections du résumé

BACKGROUND
There is scarce data evaluating the current practice pattern and clinical outcomes for patients with severe aortic stenosis (AS), including both those who underwent surgical aortic valve replacement (SAVR) or transcatheter aortic valve implantation (TAVI) and those who were managed conservatively in the TAVI era.Methods and Results: The Contemporary outcomes after sURgery and medical tREatmeNT in patients with severe Aortic Stenosis (CURRENT AS) Registry-2 is a prospective, physician-initiated, multicenter registry enrolling consecutive patients who were diagnosed with severe AS between April 2018 and December 2020 among 21 centers in Japan. The rationale for the prospective enrollment was to standardize the assessment of symptomatic status, echocardiographic evaluation, and other recommended diagnostic examinations such as computed tomography and measurement of B-type natriuretic peptide. Moreover, the schedule of clinical and echocardiographic follow up was prospectively defined and strongly recommended for patients who were managed conservatively. The entire study population consisted of 3,394 patients (mean age: 81.6 years and women: 60%). Etiology of AS was degenerative in 90% of patients. AS-related symptoms were present in 60% of patients; these were most often heart failure symptoms. The prevalence of high- and low-gradient AS was 58% and 42%, respectively, with classical and paradoxical low-flow low-gradient AS in 4.6% and 6.7%, respectively.
CONCLUSIONS
The CURRENT AS Registry-2 might be large and meticulous enough to determine the appropriate timing of intervention for patients with severe AS in contemporary clinical practice.

Identifiants

pubmed: 35444112
doi: 10.1253/circj.CJ-21-1062
doi:

Substances chimiques

Natriuretic Peptide, Brain 114471-18-0

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1769-1776

Commentaires et corrections

Type : ErratumIn

Auteurs

Yasuaki Takeji (Y)

Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University.

Tomohiko Taniguchi (T)

Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital.

Takeshi Morimoto (T)

Department of Clinical Epidemiology, Hyogo College of Medicine.

Shinichi Shirai (S)

Division of Cardiology, Kokura Memorial Hospital.

Takeshi Kitai (T)

Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital.
Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Hiroyuki Tabata (H)

Division of Cardiology, Kokura Memorial Hospital.

Kazuki Kitano (K)

Division of Cardiology, Kokura Memorial Hospital.

Nobuhisa Ono (N)

Division of Cardiovascular Surgery, Kokura Memorial Hospital.

Ryosuke Murai (R)

Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital.

Kohei Osakada (K)

Department of Cardiology, Kurashiki Central Hospital.

Koichiro Murata (K)

Department of Cardiology, Shizuoka City Shizuoka Hospital.

Masanao Nakai (M)

Department of Cardiovascular Surgery, Shizuoka City Shizuoka Hospital.

Hiroshi Tsuneyoshi (H)

Department of Cardiovascular Surgery, Shizuoka General Hospital.

Tomohisa Tada (T)

Department of Cardiology, Shizuoka General Hospital.

Masashi Amano (M)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Hiroki Shiomi (H)

Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University.

Hirotoshi Watanabe (H)

Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University.

Yusuke Yoshikawa (Y)

Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University.

Ko Yamamoto (K)

Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University.

Mamoru Toyofuku (M)

Department of Cardiology, Japanese Red Cross Wakayama Medical Center.

Shojiro Tatsushima (S)

Department of Cardiology, Japanese Red Cross Wakayama Medical Center.

Norino Kanamori (N)

Division of Cardiology, Shimada General Medical Center.

Makoto Miyake (M)

Department of Cardiology, Tenri Hospital.

Hiroyuki Nakayama (H)

Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center.

Kazuya Nagao (K)

Department of Cardiovascular Center, Osaka Red Cross Hospital.

Masayasu Izuhara (M)

Department of Cardiology, Kishiwada City Hospital.

Kenji Nakatsuma (K)

Department of Cardiology, Mitsubishi Kyoto Hospital.

Moriaki Inoko (M)

Cardiovascular Center, The Tazuke Kofukai Medical Research Institute, Kitano Hospital.

Takanari Fujita (T)

Department of Cardiology, Japanese Red Cross Wakayama Medical Center.

Masahiro Kimura (M)

Department of Cardiology, Koto Memorial Hospital.

Mitsuru Ishii (M)

Department of Cardiology, National Hospital Organization Kyoto Medical Center.

Shunsuke Usami (S)

Department of Cardiology, Kansai Electric Power Hospital.

Kenichiro Sawada (K)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Fumiko Nakazeki (F)

Department of Cardiology, Japanese Red Cross Otsu Hospital.

Marie Okabayashi (M)

Department of Cardiology, Japanese Red Cross Otsu Hospital.

Manabu Shirotani (M)

Division of Cardiology, Nara Hospital, Kinki University Faculty of Medicine.

Yasutaka Inuzuka (Y)

Department of Cardiology, Shiga General Hospital.

Tatsuhiko Komiya (T)

Department of Cardiovascular Surgery, Kurashiki Central Hospital.

Kenji Minatoya (K)

Department of Cardiovascular Surgery, Graduate School of Medicine, Kyoto University.

Takeshi Kimura (T)

Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH